Mechanism of action of the antirhinovirus flavanoid 4',6-dicyanoflavan.
4',6-Dicyanoflavan (DCF), a new antirhinovirus compound, was shown to inhibit an early event of rhinovirus type 1B replication in HeLa cells. When DCF was present from the beginning of infection or was added no later than the first hour of infection, the compound completely prevented viral RNA and protein synthesis and the virus-induced shutoff of host translation. DCF had no adverse effect either on virus binding to the cell membrane or on virus penetration into cells, whereas it delayed the uncoating kinetics of neutral redencapsidated rhinovirus. DCF also prevented mild acid or thermal inactivation of virus infectivity, although it reversibly interacted with virions. These results suggest that the stabilizing effect of DCF on virion capsid conformation is responsible for uncoating inhibition.
Conti
C
C
Istituto Pasteur-Fondazione Cenci Bolognetti, Institute of Microbiology, Rome, Italy.
Tomao
P
P
Genovese
D
D
Desideri
N
N
Stein
M L
ML
Orsi
N
N
D000998:Antiviral Agents / Q000494:pharmacology*; D002478:Cells, Cultured; D005419:Flavonoids / Q000494:pharmacology*; D006367:HeLa Cells; D006801:Humans; D012367:RNA, Viral / Q000096:biosynthesis / Q000187:drug effects; D012229:Rhinovirus / Q000187:drug effects* / Q000378:metabolism; D014764:Viral Proteins / Q000096:biosynthesis
D000998:Antiviral Agents; D005419:Flavonoids; D012367:RNA, Viral; D014764:Viral Proteins; C074588:4',6-dicyanoflavan